Organon and Co — Biomedical Watch V2

Traitements5programmes

Essais2liés

Publications0liées

SourceDBlocale

Traitements

5

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Comparator: SumatriptanA study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.	Migraine	Phase 3	À vérifier		À vérifier
rizatriptanA study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.	Migraine	Phase 3	À vérifier		À vérifier
rizatriptan benzoateTo provide long term safety data for rizatriptan in children and adolescents. The primary hypothesis of the study is that rizatriptan is well tolerated in the long term treatment of acute migraine in pediatric patients age 12-17 years.	Migraine	Phase 3	À vérifier		À vérifier
rizatriptanA study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.	Migraine	Phase 3	À vérifier		À vérifier
rizatriptan benzoateTo provide long term safety data for rizatriptan in children and adolescents. The primary hypothesis of the study is that rizatriptan is well tolerated in the long term treatment of acute migraine in pediatric patients age 12-17 years.	Migraine	Phase 3	À vérifier		À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
rizatriptan benzoate	Migraine	Phase 3	NCT01004263	A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)	COMPLETED
rizatriptan	Migraine	Phase 3	NCT00894556	A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.